KIT-18

N/A

Report date: 2025/05/23 11:38:53
NME

Base Information

Drug NameKIT-18
Drug Alias NameKIT-18
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsChondrodysplasia Punctata, Rhizomelic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuroCores Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuroCores Inc
Inactive CompaniesN/A
Active IndicationsChondrodysplasia Punctata, Rhizomelic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A